Trial Search Results
Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
The aim of the study is to see if there any changes in the quality of life for patients that are undergoing radical prostatectomy.
Stanford is currently accepting patients for this trial.
Inclusion Criteria:Patients diagnosed with liver cancer based on biopsy or serum AFP level,
associated with characteristic hypervascular liver tumors on triphasic spiral CT scan or
- Patients with non-cancer liver conditions such as cirrhosis, adenoma, cholangioma, or
- Patients with hepatitis B or hepatitis C viral infections not associated with liver
Exclusion Criteria:Patients will be excluded if, upon looking through their medical
records, information required for data analysis are missing.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study